EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study

Suzanne M Ingle, Jose M Miro, Margaret T May, Lauren E Cain, Christine Schwimmer, Robert Zangerle, Helen Sambatakou, Charles Cazanave, Peter Reiss, Vanessa Brandes, Heiner C Bucher, Caroline Sabin und 22 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciad122 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Suzanne M Ingle und 33 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, HIV Infections. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, NEI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Randomized controlled trials (RCTs) from low- and middle-income settings suggested that early initiation of antiretroviral therapy (ART) leads to higher mortality rates among people with HIV (PWH) who present with cryptococcal meningitis (CM). There is limited information about the impact of ART timing on mortality rates in similar people in high-income settings.

Methods

Data on ART-naive PWH with CM diagnosed from 1994 to 2012 from Europe/North America were pooled from the COHERE, NA-ACCORD, and CNICS HIV cohort collaborations. Follow-up was considered to span from the date of CM diagnosis to earliest of the following: death, last follow-up, or 6 months. We used marginal structural models to mimic an RCT comparing the effects of early (within 14 days of CM) and late (14–56 days after CM) ART on all-cause mortality, adjusting for potential confounders.

Results

Of 190 participants identified, 33 (17%) died within 6 months. At CM diagnosis, their median age (interquartile range) was 38 (33–44) years; the median CD4+ T-cell count, 19/μL (10–56/μL); and median HIV viral load, 5.3 (4.9–5.6) log10 copies/mL. Most participants (n = 157 [83%]) were male, and 145 (76%) started ART. Mimicking an RCT, with 190 people in each group, there were 13 deaths among participants with an early ART regimen and 20 deaths among those with a late ART regimen. The crude and adjusted hazard ratios comparing late with early ART were 1.28 (95% confidence interval, .64–2.56) and 1.40 (.66–2.95), respectively.

Conclusions

We found little evidence that early ART was associated with higher mortality rates among PWH presenting with CM in high-income settings, although confidence intervals were wide.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningitis, CryptococcalHIV InfectionsMaleHumansAdultFemaleHIVDeveloped CountriesAnti-Retroviral AgentsCohort StudiesCD4 Lymphocyte Count

Stichwörter der Autor:innen

ARTHIVcausal inferencecryptococcal meningitis

Substanzen

Anti-Retroviral Agents

Autor:innen und Institutionen

  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.
  • Infectious Diseases Service Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.
  • CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.
  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Global Epidemiology, AbbVie, Chicago, Illinois, USA.
  • University of Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC-EC 1401, Bordeaux, France.

Förderung

  • NIDA NIH HHS
  • NEI NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NCRR NIH HHS
  • NCATS NIH HHS
  • NIAAA NIH HHS
  • NIMH NIH HHS

Zitieren

APA

Ingle, S. M., Miro, J. M., May, M. T., Cain, L. E., Schwimmer, C., Zangerle, R., Sambatakou, H., Cazanave, C., Reiss, P., Brandes, V., Bucher, H. C., Sabin, C., Vidal, F., Obel, N., Mocroft, A., Wittkop, L., d'Arminio Monforte, A., Torti, C., Mussini, C., …, & Sterne, J. A. C. (2023). Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad122

Vancouver

Ingle SM, Miro JM, May MT, Cain LE, Schwimmer C, Zangerle R, et al. Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciad122

BibTeX
@article{Ingle2023,
  author = {Ingle, Suzanne M and Miro, Jose M and May, Margaret T and Cain, Lauren E and Schwimmer, Christine and Zangerle, Robert and Sambatakou, Helen and Cazanave, Charles and Reiss, Peter and Brandes, Vanessa and Bucher, Heiner C and Sabin, Caroline and Vidal, Francesc and Obel, Niels and Mocroft, Amanda and Wittkop, Linda and d'Arminio Monforte, Antonella and Torti, Carlo and Mussini, Cristina and Furrer, Hansjakob and Konopnicki, Deborah and Teira, Ramon and Saag, Michael S and Crane, Heidi M and Moore, Richard D and Jacobson, Jeffrey M and Mathews, W Chris and Geng, Elvin and Eron, Joseph J and Althoff, Keri N and Kroch, Abigail and Lang, Raynell and Gill, M John and Sterne, Jonathan A C},
  title = {Early Antiretroviral Therapy Not Associated With Higher Cryptococcal Meningitis Mortality in People With Human Immunodeficiency Virus in High-Income Countries: An International Collaborative Cohort Study},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciad122}
}
Kostenlos starten →